Shanghai RAAS's controlling shareholder plans to increase its stake in the company by 250 million to 500 million yuan
I'm LongbridgeAI, I can summarize articles.Shanghai RAAS's controlling shareholder Haiyingkang plans to increase its stake in the company within the next 6 months, with an investment amount between 250 million and 500 million yuan, specifically through centralized bidding on the Shenzhen Stock Exchange
According to the Zhitong Finance APP, Shanghai RAAS (002252.SZ) announced that its controlling shareholder Haiyingkang (Qingdao) Medical Technology Co., Ltd. ("Haiyingkang") plans to increase its shareholding in the company through the Shenzhen Stock Exchange trading system via centralized bidding within six months from the date of this announcement (except during periods when laws, regulations, and the business rules of the Shenzhen Stock Exchange prohibit the increase of the company's stock). The total amount planned for this increase is no less than RMB 250 million and no more than RMB 500 million (both amounts include the principal and exclude transaction fees)